The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders

Cell Metabolism

Volumn 17, Issue 4, 2013, Pages 475-490

  Silvestri, Cristoforo ^a   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR 1 INVERSE AGONIST; CANNABINOID RECEPTOR 1 NEUTRAL ANTAGONIST; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DIACYLGLYCEROL LIPASE INHIBITOR; DOCOSAHEXAENOIC ACID; ENDOCANNABINOID; ENZYME INHIBITOR; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; CALORIC INTAKE; CALORIC RESTRICTION; DIET; ENERGY METABOLISM; EXERCISE; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; LIVER; METABOLIC DISORDER; NONHUMAN; OBESITY; PANCREAS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; THERMOGENESIS; UNSPECIFIED SIDE EFFECT;

ADIPOSE TISSUE; ENDOCANNABINOIDS; ENERGY METABOLISM; GLUCOSE; HUMANS; INSULIN RESISTANCE; METABOLIC DISEASES; RECEPTOR, CANNABINOID, CB1;

EID: 84875879626     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.03.001     Document Type: Review

References (151)

1. M.A. Abdul-Ghani, and R.A. DeFronzo Pathogenesis of insulin resistance in skeletal muscle J. Biomed. Biotechnol. 2010 2010 476279
2. C. Addy, H. Wright, K. Van Laere, I. Gantz, N. Erondu, B.J. Musser, K. Lu, J. Yuan, S.M. Sanabria-Bohórquez, and A. Stoch The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake Cell Metab. 7 2008 68 78
3. J. Agudo, M. Martin, C. Roca, M. Molas, A.S. Bura, A. Zimmer, F. Bosch, and R. Maldonado Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age Diabetologia 53 2010 2629 2640
4. M. Ahmadian, Y. Wang, and H.S. Sul Lipolysis in adipocytes Int. J. Biochem. Cell Biol. 42 2010 555 559
5. A.R. Alvheim, M.K. Malde, D. Osei-Hyiaman, Y.H. Lin, R.J. Pawlosky, L. Madsen, K. Kristiansen, L. Frøyland, and J.R. Hibbeln Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity Obesity (Silver Spring) 20 2012 1984 1994
6. G. Annuzzi, F. Piscitelli, L. Di Marino, L. Patti, R. Giacco, G. Costabile, L. Bozzetto, G. Riccardi, R. Verde, and S. Petrosino Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients Lipids Health Dis. 9 2010 43
7. M. Bajzer, M. Olivieri, M.K. Haas, P.T. Pfluger, I.J. Magrisso, M.T. Foster, M.H. Tschöp, K.A. Krawczewski-Carhuatanta, D. Cota, and S. Obici Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice Diabetologia 54 2011 3121 3131
8. S. Banni, G. Carta, E. Murru, L. Cordeddu, E. Giordano, A.R. Sirigu, K. Berge, H. Vik, K.C. Maki, V. Di Marzo, and M. Griinari Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects Nutr. Metab. (Lond) 8 2011 7
9. B. Batetta, M. Griinari, G. Carta, E. Murru, A. Ligresti, L. Cordeddu, E. Giordano, F. Sanna, T. Bisogno, and S. Uda Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats J. Nutr. 139 2009 1495 1501
10. L. Bellocchio, P. Lafenêtre, A. Cannich, D. Cota, N. Puente, P. Grandes, F. Chaouloff, P.V. Piazza, and G. Marsicano Bimodal control of stimulated food intake by the endocannabinoid system Nat. Neurosci. 13 2010 281 283
11. M.F. Bennetzen, N. Wellner, S.S. Ahmed, S.M. Ahmed, T.A. Diep, H.S. Hansen, B. Richelsen, and S.B. Pedersen Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss Int J Obes (Lond) 35 2011 1377 1384
12. M. Bensaid, M. Gary-Bobo, A. Esclangon, J.P. Maffrand, G. Le Fur, F. Oury-Donat, and P. Soubrié The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells Mol. Pharmacol. 63 2003 908 914
13. F.J. Bermúdez-Silva, J. Suárez, E. Baixeras, N. Cobo, D. Bautista, A.L. Cuesta-Muñoz, E. Fuentes, P. Juan-Pico, M.J. Castro, and G. Milman Presence of functional cannabinoid receptors in human endocrine pancreas Diabetologia 51 2008 476 487
14. F.J. Bermúdez-Siva, A. Serrano, F.J. Diaz-Molina, I. Sánchez Vera, P. Juan-Pico, A. Nadal, E. Fuentes, and F. Rodríguez de Fonseca Activation of cannabinoid CB1 receptors induces glucose intolerance in rats Eur. J. Pharmacol. 531 2006 282 284
15. T. Bisogno, J.J. Burston, R. Rai, M. Allarà, B. Saha, A. Mahadevan, R.K. Razdan, J.L. Wiley, and V. Di Marzo Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol ChemMedChem 4 2009 946 950
16. T. Bisogno, A. Mahadevan, R. Coccurello, J.W. Chang, M. Allarà, Y. Chen, G. Giacovazzo, A. Lichtman, B. Cravatt, A. Moles, and V. Di Marzo A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects Br. J. Pharmacol. 2012 10.1111/bph.12013 Published online October 16, 2012
17. M. Blüher, S. Engeli, N. Klöting, J. Berndt, M. Fasshauer, S. Bátkai, P. Pacher, M.R. Schön, J. Jordan, and M. Stumvoll Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity Diabetes 55 2006 3053 3060
18. M. Bouaboula, S. Hilairet, J. Marchand, L. Fajas, G. Le Fur, and P. Casellas Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation Eur. J. Pharmacol. 517 2005 174 181
19. C. Broberger Brain regulation of food intake and appetite: molecules and networks J. Intern. Med. 258 2005 301 327
20. I. Brown, M.G. Cascio, D. Rotondo, R.G. Pertwee, S.D. Heys, and K.W. Wahle Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators Prog. Lipid Res. 52 2013 80 109
21. C. Buettner, E.D. Muse, A. Cheng, L. Chen, T. Scherer, A. Pocai, K. Su, B. Cheng, X. Li, and J. Harvey-White Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms Nat. Med. 14 2008 667 675
22. J.C. Cable, G.D. Tan, S.P. Alexander, and S.E. O'Sullivan The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans Lipids Health Dis. 10 2011 129
23. P. Cardinal, L. Bellocchio, S. Clark, A. Cannich, M. Klugmann, B. Lutz, G. Marsicano, and D. Cota Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice Endocrinology 153 2012 4136 4143
24. P. Cavuoto, A.J. McAinch, G. Hatzinikolas, D. Cameron-Smith, and G.A. Wittert Effects of cannabinoid receptors on skeletal muscle oxidative pathways Mol. Cell. Endocrinol. 267 2007 63 69
25. P. Cavuoto, A.J. McAinch, G. Hatzinikolas, A. Janovská, P. Game, and G.A. Wittert The expression of receptors for endocannabinoids in human and rodent skeletal muscle Biochem. Biophys. Res. Commun. 364 2007 105 110
26. D. Chanda, D.K. Kim, T. Li, Y.H. Kim, S.H. Koo, C.H. Lee, J.Y. Chiang, and H.S. Choi Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes J. Biol. Chem. 286 2011 27971 27979
27. S.H. Chon, J.D. Douglass, Y.X. Zhou, N. Malik, J.L. Dixon, A. Brinker, L. Quadro, and J. Storch Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity PLoS ONE 7 2012 e43962
28. G. Colombo, R. Agabio, G. Diaz, C. Lobina, R. Reali, and G.L. Gessa Appetite suppression and weight loss after the cannabinoid antagonist SR 141716 Life Sci. 63 1998 PL113 PL117
29. D. Cota, G. Marsicano, M. Tschöp, Y. Grübler, C. Flachskamm, M. Schubert, D. Auer, A. Yassouridis, C. Thöne-Reineke, and S. Ortmann The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis J. Clin. Invest. 112 2003 423 431
30. M. Côté, I. Matias, I. Lemieux, S. Petrosino, N. Alméras, J.P. Després, and V. Di Marzo Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men Int J Obes (Lond) 31 2007 692 699
31. A. Crespillo, J. Suárez, F.J. Bermúdez-Silva, P. Rivera, M. Vida, M. Alonso, A. Palomino, M.A. Lucena, A. Serrano, and M. Pérez-Martín Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade Biochem. J. 433 2011 175 185
32. K.M. Crosby, W. Inoue, Q.J. Pittman, and J.S. Bains Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits Neuron 71 2011 529 541
33. E. D'Asti, H. Long, J. Tremblay-Mercier, M. Grajzer, S.C. Cunnane, V. Di Marzo, and C.D. Walker Maternal dietary fat determines metabolic profile and the magnitude of endocannabinoid inhibition of the stress response in neonatal rat offspring Endocrinology 151 2010 1685 1694
34. T.M. D'Eon, K.A. Pierce, J.J. Roix, A. Tyler, H. Chen, and S.R. Teixeira The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids Diabetes 57 2008 1262 1268
35. A. De Gottardi, L. Spahr, F. Ravier-Dall'Antonia, and A. Hadengue Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes Liver Int. 30 2010 1482 1489
36. M.A. De Luca, M. Solinas, Z. Bimpisidis, S.R. Goldberg, and G. Di Chiara Cannabinoid facilitation of behavioral and biochemical hedonic taste responses Neuropharmacology 63 2012 161 168
37. D.A. de Luis, M.G. Sagrado, D. Pacheco, M.C. Terroba, T. Martin, L. Cuellar, and M. Ventosa Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery Surg. Obes. Relat. Dis. 6 2010 516 520
38. V. Deveaux, T. Cadoudal, Y. Ichigotani, F. Teixeira-Clerc, A. Louvet, S. Manin, J.T. Nhieu, M.P. Belot, A. Zimmer, and P. Even Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis PLoS ONE 4 2009 e5844
39. V. Di Marzo The endocannabinoid system in obesity and type 2 diabetes Diabetologia 51 2008 1356 1367
40. V. Di Marzo Endocannabinoids: synthesis and degradation Rev. Physiol. Biochem. Pharmacol. 160 2008 1 24
41. V. Di Marzo, and L. De Petrocellis Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs Curr. Med. Chem. 17 2010 1430 1449
42. V. Di Marzo, S.K. Goparaju, L. Wang, J. Liu, S. Bátkai, Z. Járai, F. Fezza, G.I. Miura, R.D. Palmiter, T. Sugiura, and G. Kunos Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 2001 822 825
43. V. Di Marzo, M. Côté, I. Matias, I. Lemieux, B.J. Arsenault, A. Cartier, F. Piscitelli, S. Petrosino, N. Alméras, and J.P. Després Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors Diabetologia 52 2009 213 217
44. V. Di Marzo, A. Ligresti, and L. Cristino The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation Int J Obes (Lond) 33 Suppl 2 2009 S18 S24
45. V. Di Marzo, A. Verrijken, A. Hakkarainen, S. Petrosino, I. Mertens, N. Lundbom, F. Piscitelli, J. Westerbacka, A. Soro-Paavonen, and I. Matias Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects Eur. J. Endocrinol. 161 2009 715 722
46. V. Di Marzo, M. Griinari, G. Carta, E. Murru, A. Ligresti, L. Cordeddu, E. Giordano, T. Bisogno, M. Collu, and B. Batetta Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats International Dairy Journal 20 2010 231 235
47. N.V. DiPatrizio, G. Astarita, G. Schwartz, X. Li, and D. Piomelli Endocannabinoid signal in the gut controls dietary fat intake Proc. Natl. Acad. Sci. USA 108 2011 12904 12908
48. Y. Dong, M. Zhang, B. Liang, Z. Xie, Z. Zhao, S. Asfa, H.C. Choi, and M.H. Zou Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo Circulation 121 2010 792 803
49. K. Eckardt, H. Sell, A. Taube, M. Koenen, B. Platzbecker, A. Cramer, A. Horrighs, M. Lehtonen, N. Tennagels, and J. Eckel Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle Diabetologia 52 2009 664 674
50. S. Engeli, J. Böhnke, M. Feldpausch, K. Gorzelniak, J. Janke, S. Bátkai, P. Pacher, J. Harvey-White, F.C. Luft, A.M. Sharma, and J. Jordan Activation of the peripheral endocannabinoid system in human obesity Diabetes 54 2005 2838 2843
51. I. Esposito, M.C. Proto, P. Gazzerro, C. Laezza, C. Miele, A.T. Alberobello, V. D'Esposito, F. Beguinot, P. Formisano, and M. Bifulco The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3- kinase Mol. Pharmacol. 74 2008 1678 1686
52. F. Fanelli, V.D. Di Lallo, I. Belluomo, R. De Iasio, M. Baccini, E. Casadio, D.I. Gasparini, M. Colavita, A. Gambineri, and G. Grossi Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS J. Lipid Res. 53 2012 481 493
53. M. Flamment, N. Gueguen, C. Wetterwald, G. Simard, Y. Malthièry, and P.H. Ducluzeau Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet Am. J. Physiol. Endocrinol. Metab. 297 2009 E1162 E1170
54. Y. Gaoni, and R. Mechoulam Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish J. Am. Chem. Soc. 86 1964 1646 1647
55. M. Gary-Bobo, G. Elachouri, J.F. Gallas, P. Janiak, P. Marini, C. Ravinet-Trillou, M. Chabbert, N. Cruccioli, C. Pfersdorff, and C. Roque Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats Hepatology 46 2007 122 129
56. V. Gasperi, F. Fezza, N. Pasquariello, M. Bari, S. Oddi, A.F. Agrò, and M. Maccarrone Endocannabinoids in adipocytes during differentiation and their role in glucose uptake Cell. Mol. Life Sci. 64 2007 219 229
57. B. Gatta-Cherifi, I. Matias, M. Vallée, A. Tabarin, G. Marsicano, P.V. Piazza, and D. Cota Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity Int J Obes (Lond) 36 2012 880 885
58. Q. Ge, E. Maury, L. Rycken, J. Gérard, L. Noël, R. Detry, B. Navez, and S.M. Brichard Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity Int J Obes (Lond) 2012 10.1038/ijo.2012.123 in press. Published online August 7, 2012
59. L. Getty-Kaushik, A.M. Richard, J.T. Deeney, S. Krawczyk, O. Shirihai, and B.E. Corkey The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets Obesity (Silver Spring) 17 2009 1856 1860
60. H.S. Hansen, M.M. Rosenkilde, J.J. Holst, and T.W. Schwartz GPR119 as a fat sensor Trends Pharmacol. Sci. 33 2012 374 381
61. A.W. Herling, S. Kilp, R. Elvert, G. Haschke, and W. Kramer Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats Endocrinology 149 2008 2557 2566
62. E. Heyman, F.X. Gamelin, J. Aucouturier, and V. Di Marzo The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity Obes. Rev. 13 2012 1110 1124
63. S. Higuchi, M. Ohji, M. Araki, R. Furuta, M. Katsuki, R. Yamaguchi, Y. Akitake, K. Matsuyama, K. Irie, and K. Mishima Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors Behav. Brain Res. 216 2011 477 480
64. A.C. Howlett Pharmacology of cannabinoid receptors Annu. Rev. Pharmacol. Toxicol. 35 1995 607 634
65. P.S. Hsieh, K.C. Lu, C.F. Chiang, and C.H. Chen Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats Eur. J. Clin. Invest. 40 2010 164 171
66. A.A. Izzo, F. Piscitelli, R. Capasso, G. Aviello, B. Romano, F. Borrelli, S. Petrosino, and V. Di Marzo Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding Br. J. Pharmacol. 158 2009 451 461
67. N. Jamshidi, and D.A. Taylor Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats Br. J. Pharmacol. 134 2001 1151 1154
68. W.I. Jeong, D. Osei-Hyiaman, O. Park, J. Liu, S. Bátkai, P. Mukhopadhyay, N. Horiguchi, J. Harvey-White, G. Marsicano, and B. Lutz Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver Cell Metab. 7 2008 227 235
69. Y.H. Jo, Y.J. Chen, S.C. Chua Jr., D.A. Talmage, and L.W. Role Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit Neuron 48 2005 1055 1066
70. T. Jourdan, L. Djaouti, L. Demizieux, J. Gresti, B. Vergès, and P. Degrace CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice Diabetes 59 2010 926 934
71. T. Jourdan, L. Demizieux, J. Gresti, L. Djaouti, L. Gaba, B. Vergès, and P. Degrace Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants Hepatology 55 2012 790 799
72. K.M. Jung, J.R. Clapper, J. Fu, G. D'Agostino, A. Guijarro, D. Thongkham, A. Avanesian, G. Astarita, N.V. DiPatrizio, and A. Frontini 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism Cell Metab. 15 2012 299 310
73. S. Karaliota, A. Siafaka-Kapadai, C. Gontinou, K. Psarra, and M. Mavri-Vavayanni Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation Obesity (Silver Spring) 17 2009 1830 1838
74. W. Kim, M.E. Doyle, Z. Liu, Q. Lao, Y.K. Shin, O.D. Carlson, H.S. Kim, S. Thomas, J.K. Napora, and E.K. Lee Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells Diabetes 60 2011 1198 1209
75. S.P. Kim, O.O. Woolcott, I.R. Hsu, D. Stefanoski, L.N. Harrison, D. Zheng, M. Lottati, C. Kolka, K.J. Catalano, and J.D. Chiu CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs Am. J. Physiol. Endocrinol. Metab. 302 2012 E1261 E1268
76. W. Kim, Q. Lao, Y.K. Shin, O.D. Carlson, E.K. Lee, M. Gorospe, R.N. Kulkarni, and J.M. Egan Cannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor activation Sci. Signal. 5 2012 ra23
77. J.E. Kinsella Lipids, membrane receptors, and enzymes: effects of dietary fatty acids JPEN J. Parenter. Enteral Nutr. 14 5, Suppl 1990 200S 217S
78. T.C. Kirkham, C.M. Williams, F. Fezza, and V. Di Marzo Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol Br. J. Pharmacol. 136 2002 550 557
79. B. Kola, E. Hubina, S.A. Tucci, T.C. Kirkham, E.A. Garcia, S.E. Mitchell, L.M. Williams, S.A. Hawley, D.G. Hardie, A.B. Grossman, and M. Korbonits Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase J. Biol. Chem. 280 2005 25196 25201
80. B. Kola, I. Farkas, M. Christ-Crain, G. Wittmann, F. Lolli, F. Amin, J. Harvey-White, Z. Liposits, G. Kunos, and A.B. Grossman The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system PLoS ONE 3 2008 e1797
81. K.R. Kozak, B.C. Crews, J.D. Morrow, L.H. Wang, Y.H. Ma, R. Weinander, P.J. Jakobsson, and L.J. Marnett Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides J. Biol. Chem. 277 2002 44877 44885
82. K.R. Kozak, J.J. Prusakiewicz, and L.J. Marnett Oxidative metabolism of endocannabinoids by COX-2 Curr. Pharm. Des. 10 2004 659 667
83. 1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications Br. J. Pharmacol. 163 2011 1423 1431
84. I. Kunz, M.K. Meier, A. Bourson, M. Fisseha, and W. Schilling Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats Int J Obes (Lond) 32 2008 863 870
85. M. Lafourcade, T. Larrieu, S. Mato, A. Duffaud, M. Sepers, I. Matias, V. De Smedt-Peyrusse, V.F. Labrousse, L. Bretillon, and C. Matute Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions Nat Neurosci. 14 2011 345 350
86. H. Lan, H.V. Lin, C.F. Wang, M.J. Wright, S. Xu, L. Kang, K. Juhl, J.A. Hedrick, and T.J. Kowalski Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways Br. J. Pharmacol. 165 2012 2799 2807
87. C. Li, P.M. Jones, and S.J. Persaud Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells Cell. Physiol. Biochem. 26 2010 187 196
88. K.A. Lindborg, M.K. Teachey, S. Jacob, and E.J. Henriksen Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle Diabetes Obes. Metab. 12 2010 722 730
89. K.A. Lindborg, S. Jacob, and E.J. Henriksen Effects of Chronic Antagonism of Endocannabinoid-1 Receptors on Glucose Tolerance and Insulin Action in Skeletal Muscles of Lean and Obese Zucker Rats Cardiorenal Med 1 2011 31 44
90. C. Lipina, C. Stretton, S. Hastings, J.S. Hundal, K. Mackie, A.J. Irving, and H.S. Hundal Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells Diabetes 59 2010 375 385
91. Y.L. Liu, I.P. Connoley, C.A. Wilson, and M.J. Stock Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice Int J Obes (Lond) 29 2005 183 187
92. J. Liu, L. Zhou, K. Xiong, G. Godlewski, B. Mukhopadhyay, J. Tam, S. Yin, P. Gao, X. Shan, and J. Pickel Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice Gastroenterology 142 2012 1218 1228 e1
93. S.H. Lockie, T.A. Czyzyk, N. Chaudhary, D. Perez-Tilve, S.C. Woods, B.J. Oldfield, M.A. Statnick, and M.H. Tschöp CNS opioid signaling separates cannabinoid receptor 1-mediated effects on body weight and mood-related behavior in mice Endocrinology 152 2011 3661 3667
94. Z. Luo, L. Ma, Z. Zhao, H. He, D. Yang, X. Feng, S. Ma, X. Chen, T. Zhu, and T. Cao TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in mice Cell Res. 22 2012 551 564
95. M. Majer, K.M. Popov, R.A. Harris, C. Bogardus, and M. Prochazka Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects Mol. Genet. Metab. 65 1998 181 186
96. R. Malcher-Lopes, S. Di, V.S. Marcheselli, F.J. Weng, C.T. Stuart, N.G. Bazan, and J.G. Tasker Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release J. Neurosci. 26 2006 6643 6650
97. Mancini, G., Quarta, C., Srivastava, R.K., Klaus, S., Pagotto, U., and Lutz, B. (2010). Adipocyte-specific CB1 conditional knock-out mice: new insights in the study of obesity and metabolic syndrome. Paper presented at the 20th Annual Symposium of the International Cannabinoid Research Society (Lund, Sweden).
98. F. Massa, G. Mancini, H. Schmidt, F. Steindel, K. Mackie, C. Angioni, S.H. Oliet, G. Geisslinger, and B. Lutz Alterations in the hippocampal endocannabinoid system in diet-induced obese mice J. Neurosci. 30 2010 6273 6281
99. I. Matias, M.P. Gonthier, P. Orlando, V. Martiadis, L. De Petrocellis, C. Cervino, S. Petrosino, L. Hoareau, F. Festy, and R. Pasquali Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia J. Clin. Endocrinol. Metab. 91 2006 3171 3180
100. I. Matias, G. Carta, E. Murru, S. Petrosino, S. Banni, and V. Di Marzo Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes Biochim. Biophys. Acta 1781 2008 52 60
101. I. Matias, S. Petrosino, A. Racioppi, R. Capasso, A.A. Izzo, and V. Di Marzo Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets Mol. Cell. Endocrinol. 286 1-2, Suppl 1 2008 S66 S78
102. T. Melis, S. Succu, F. Sanna, A. Boi, A. Argiolas, and M.R. Melis The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food Neurosci. Lett. 419 2007 231 235
103. N. Mendez-Sanchez, D. Zamora-Valdes, R. Pichardo-Bahena, B. Barredo-Prieto, G. Ponciano-Rodriguez, L. Bermejo-Martínez, N.C. Chavez-Tapia, H.A. Baptista-González, and M. Uribe Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease Liver Int. 27 2007 215 219
104. S. Mølhøj, H.S. Hansen, M. Schweiger, R. Zimmermann, T. Johansen, and K. Malmlöf Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats Eur. J. Pharmacol. 646 2010 38 45
105. P. Monteleone, F. Piscitelli, P. Scognamiglio, A.M. Monteleone, B. Canestrelli, V. Di Marzo, and M. Maj Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study J. Clin. Endocrinol. Metab. 97 2012 E917 E924
106. G.G. Muccioli Endocannabinoid biosynthesis and inactivation, from simple to complex Drug Discov. Today 15 2010 474 483
107. B. Mukhopadhyay, J. Liu, D. Osei-Hyiaman, G. Godlewski, P. Mukhopadhyay, L. Wang, W.I. Jeong, B. Gao, G. Duester, and K. Mackie Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma J. Biol. Chem. 285 2010 19002 19011
108. G. Murdolo, K. Kempf, A. Hammarstedt, C. Herder, U. Smith, and P.A. Jansson Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals J. Endocrinol. Invest. 30 2007 RC17 RC21
109. D.K. Nomura, B.E. Morrison, J.L. Blankman, J.Z. Long, S.G. Kinsey, M.C. Marcondes, A.M. Ward, Y.K. Hahn, A.H. Lichtman, B. Conti, and B.F. Cravatt Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation Science 334 2011 809 813
110. J.D. O'Hare, E. Zielinski, B. Cheng, T. Scherer, and C. Buettner Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysis Diabetes 60 2011 1055 1062
111. T. Ohno-Shosaku, A. Tanimura, Y. Hashimotodani, and M. Kano Endocannabinoids and retrograde modulation of synaptic transmission Neuroscientist 18 2012 119 132
112. D. Osei-Hyiaman, M. DePetrillo, P. Pacher, J. Liu, S. Radaeva, S. Bátkai, J. Harvey-White, K. Mackie, L. Offertáler, L. Wang, and G. Kunos Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity J. Clin. Invest. 115 2005 1298 1305
113. D. Osei-Hyiaman, J. Liu, L. Zhou, G. Godlewski, J. Harvey-White, W.I. Jeong, S. Bátkai, G. Marsicano, B. Lutz, C. Buettner, and G. Kunos Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice J. Clin. Invest. 118 2008 3160 3169
114. P. Pacher, and R. Mechoulam Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog. Lipid Res. 50 2011 193 211
115. C. Pagano, C. Pilon, A. Calcagno, R. Urbanet, M. Rossato, G. Milan, K. Bianchi, R. Rizzuto, P. Bernante, G. Federspil, and R. Vettor The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms J. Clin. Endocrinol. Metab. 92 2007 4810 4819
116. U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali The emerging role of the endocannabinoid system in endocrine regulation and energy balance Endocr. Rev. 27 2006 73 100
117. Z. Pang, N.N. Wu, W. Zhao, D.C. Chain, E. Schaffer, X. Zhang, P. Yamdagni, V.A. Palejwala, C. Fan, and S.G. Favara The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice Obesity (Silver Spring) 19 2011 1923 1934
118. S. Parekh, and F.A. Anania Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease Gastroenterology 132 2007 2191 2207
119. R.G. Pertwee, and R.A. Ross Cannabinoid receptors and their ligands Prostaglandins Leukot. Essent. Fatty Acids 66 2002 101 121
120. N. Perwitz, M. Fasshauer, and J. Klein Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin Horm. Metab. Res. 38 2006 356 358
121. S. Pinto, A.G. Roseberry, H. Liu, S. Diano, M. Shanabrough, X. Cai, J.M. Friedman, and T.L. Horvath Rapid rewiring of arcuate nucleus feeding circuits by leptin Science 304 2004 110 115
122. F. Piscitelli, G. Carta, T. Bisogno, E. Murru, L. Cordeddu, K. Berge, S. Tandy, J.S. Cohn, M. Griinari, S. Banni, and V. Di Marzo Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice Nutr. Metab. (Lond) 8 2011 51
123. C. Postic, and J. Girard Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice J. Clin. Invest. 118 2008 829 838
124. C. Postic, and J. Girard The role of the lipogenic pathway in the development of hepatic steatosis Diabetes Metab. 34 2008 643 648
125. C. Quarta, L. Bellocchio, G. Mancini, R. Mazza, C. Cervino, L.J. Braulke, C. Fekete, R. Latorre, C. Nanni, and M. Bucci CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance Cell Metab. 11 2010 273 285
126. C. Ravinet Trillou, C. Delgorge, C. Menet, M. Arnone, and P. Soubrié CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity Int. J. Obes. Relat. Metab. Disord. 28 2004 640 648
127. R. Roche, L. Hoareau, S. Bes-Houtmann, M.P. Gonthier, C. Laborde, J.F. Baron, Y. Haffaf, M. Cesari, and F. Festy Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes Histochem. Cell Biol. 126 2006 177 187
128. K. Rohrbach, M.A. Thomas, S. Glick, E.N. Fung, V. Wang, L. Watson, P. Gregory, J. Antel, and M.A. Pelleymounter Ibipinabant attenuates β-cell loss in male Zucker diabetic fatty rats independently of its effects on body weight Diabetes Obes. Metab. 14 2012 555 564
129. S.Y. Romero-Zerbo, M.S. Garcia-Gutierrez, J. Suárez, P. Rivera, I. Ruz-Maldonado, M. Vida, F. Rodriguez de Fonseca, J. Manzanares, and F.J. Bermúdez-Silva Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice J. Neuroendocrinol. 24 2012 1106 1119
130. M. Rossmeisl, Z.M. Jilkova, O. Kuda, T. Jelenik, D. Medrikova, B. Stankova, B. Kristinsson, G.G. Haraldsson, H. Svensen, and I. Stoknes Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids PLoS ONE 7 2012 e38834
131. M.A. Ruby, D.K. Nomura, C.S. Hudak, A. Barber, J.E. Casida, and R.M. Krauss Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes PLoS ONE 6 2011 e26415
132. T. Scherer, C. Lindtner, E. Zielinski, J. O'Hare, N. Filatova, and C. Buettner Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis J. Biol. Chem. 287 2012 33061 33069
133. G.J. Schwartz, J. Fu, G. Astarita, X. Li, S. Gaetani, P. Campolongo, V. Cuomo, and D. Piomelli The lipid messenger OEA links dietary fat intake to satiety Cell Metab. 8 2008 281 288
134. C. Silvestri, and V. Di Marzo Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders Expert Opin. Investig. Drugs 21 2012 1309 1322
135. C. Silvestri, A. Ligresti, and V. Di Marzo Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle Rev. Endocr. Metab. Disord. 12 2011 153 162
136. J.C. Sipe, T.M. Scott, S. Murray, O. Harismendy, G.M. Simon, B.F. Cravatt, and J. Waalen Biomarkers of endocannabinoid system activation in severe obesity PLoS ONE 5 2010 e8792
137. D. Song, R.H. Bandsma, C. Xiao, L. Xi, W. Shao, T. Jin, and G.F. Lewis Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice Diabetologia 54 2011 1181 1189
138. K.M. Starowicz, L. Cristino, I. Matias, R. Capasso, A. Racioppi, A.A.
139. A.J. Tallett, J.E. Blundell, and R.J. Rodgers Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats Pharmacol. Biochem. Behav. 91 2009 358 366
140. J. Tam, V.K. Vemuri, J. Liu, S. Bátkai, B. Mukhopadhyay, G. Godlewski, D. Osei-Hyiaman, S. Ohnuma, S.V. Ambudkar, and J. Pickel Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity J. Clin. Invest. 120 2010 2953 2966
141. J. Tam, R. Cinar, J. Liu, G. Godlewski, D. Wesley, T. Jourdan, G. Szanda, B. Mukhopadhyay, L. Chedester, and J.S. Liow Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance Cell Metab. 16 2012 167 179
142. U. Taschler, F.P. Radner, C. Heier, R. Schreiber, M. Schweiger, G. Schoiswohl, K. Preiss-Landl, D. Jaeger, B. Reiter, and H.C. Koefeler Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance J. Biol. Chem. 286 2011 17467 17477
143. L. Tedesco, A. Valerio, M. Dossena, A. Cardile, M. Ragni, C. Pagano, U. Pagotto, M.O. Carruba, R. Vettor, and E. Nisoli Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways Diabetes 59 2010 2826 2836
144. C. Touriño, F. Oveisi, J. Lockney, D. Piomelli, and R. Maldonado FAAH deficiency promotes energy storage and enhances the motivation for food Int J Obes (Lond) 34 2010 557 568
145. V. Vaidyanathan, R.A. Bastarrachea, P.B. Higgins, V.S. Voruganti, S. Kamath, N.V. DiPatrizio, D. Piomelli, A.G. Comuzzie, and E.J. Parks Selective cannabinoid-1 receptor blockade benefits fatty acid and triglyceride metabolism significantly in weight-stable nonhuman primates Am. J. Physiol. Endocrinol. Metab. 303 2012 E624 E634
146. A.N. Verty, I.S. McGregor, and P.E. Mallet The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol Brain Res. 1020 2004 188 195
147. R. Vettor, and C. Pagano The role of the endocannabinoid system in lipogenesis and fatty acid metabolism Best Pract. Res. Clin. Endocrinol. Metab. 23 2009 51 63
148. B. Viollet, B. Guigas, J. Leclerc, S. Hébrard, L. Lantier, R. Mounier, F. Andreelli, and M. Foretz AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives Acta Physiol. (Oxf.) 196 2009 81 98
149. H.M. Wu, Y.M. Yang, and S.G. Kim Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition Mol. Pharmacol. 80 2011 859 869
150. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, and K. Ueki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat. Med. 8 2002 1288 1295
151. Z.C. Yan, D.Y. Liu, L.L. Zhang, C.Y. Shen, Q.L. Ma, T.B. Cao, L.J. Wang, H. Nie, W. Zidek, M. Tepel, and Z.M. Zhu Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta Biochem. Biophys. Res. Commun. 354 2007 427 433